CIPLA QUALITY CHEMICALS INDUSTRIES LIMITED (CQCIL)


GALLERY OF NG

CQCIL is a state-of-the-art pharmaceutical manufacturer in Kampala, Uganda, which focuses on producing high-quality WHO pre-qualified first-line treatments for HIV/Aids, Malaria and Hepatitis B

Key Features:
  • Focus: HIV/AIDS, Malaria and, more recently, Hepatitis B
  • One of four pharmaceutical manufacturers in sub-Saharan Africa to receive the WHO’s Good Manufacturing Practices Certifications
  • Currently approved in 13 countries (up from eight in March 2016) across Eastern and Southern Africa
  • CQCIL products are expected to be registered in 20 sub-Sahara African countries by the end of 2020
  • Total plant capacity is 130 million tablets/month, up from 25 million tablets/month in 2009
  • CQCIL listed on the Uganda Stock Exchange (USE) on 17th September 2018, the first IPO in Uganda since 2011